The organization hopes to collect data to provide better education around Thrombosis.
The International Society on Thrombosis and Haemostasis (ISTH) recognized World Thrombosis Day on October 13.1 The day is part of a global campaign established by the organization with a goal of increasing education on the signs, symptoms, risk factors, and prevention of blood clots. According to a press release from the organization, about one in four deaths are associated with thrombosis.
ISTH released a survey to the public to collect data about women and the risks of blood clots during pregnancy, after the pregnancy, and during other critical life stages.
In a press release, chair of the World Thrombosis Day Steering Committee Lana Castellucci, MD, said, “Understanding the risks of blood clots is crucial, as one in four people die worldwide from conditions caused by thrombosis. Raising awareness about VTE can ensure better care for those at risk. This year, we are particularly focused on women's health and thrombosis. By gathering data through this survey, we aim to understand women's experiences with VTE education during pregnancy and postpartum and hope to empower women with knowledge and improve health outcomes for themselves and their families."
Last year, the ISTH celebrated its 10th anniversary on World Thrombosis Day.2 In a press release issued at the time, Castellucci said, “One of the reasons that thrombosis ends up as the cause of death for one in four people worldwide is that many of its symptoms are synonymous with other common conditions. When a person experiences a leg cramp, for example, it is unlikely that they will seek a blood clot screening, and unfortunately, that can result in the condition becoming fatal. We are working to educate the public on the signs and symptoms of this prevalent condition to ensure proper medical care is sought before it's too late."
In June of this year, the ISTH launched a new educational initiative called ISTH Emerging Therapies in Thrombosis–Factor XI/Xia Inhibitors.3 The global program’s goal is to raise awareness among physicians about factor XI inhibition and the role it may potentially play in anticoagulation therapies.
In a press release issued at the time, the ISTH secretary general for its 2024-2028 term Jeff Weitz, MD, said, “Launching the factor XI/XIa educational roadmap in Bangkok is an exciting opportunity to kick off this global education initiative. Our leadership in the steering committee and feedback from the greater thrombosis and hemostasis community has allowed us to understand the current needs and create meaningful education in factor XI/XIa inhibition."
Also in June, the ISTH published a clinical practice guideline for utilizing strict GRADE methodology when treating congenital hemophilia A and B.4 GRADE stands for grading of recommendations assessments, development, and evaluation.
In a press release issued at the time, ISTH’s chair of its hemophilia guideline panel Suely M. Rezenda, MD, PhD, said, “With hemophilia management being complex, our guideline provides clarity, guiding treatment decisions with evidence-based insight, yet highlighting the importance of making treatment decisions consistent with patients' individual risks, values, and preferences. Our collaborative effort has yielded a roadmap for optimizing patient care, setting a new standard in hemophilia treatment guidelines."
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
Patient Engagement Throughout the Entire Product Lifecycle (October 2024)
October 17th 2024In the pharmaceutical industry, patient engagement should be centered in health education, communication, and strategy during drug discovery and throughout the product lifecycle. Cheryl Lubbert, CEO of Reverba, discusses the importance of a patient-first mindset in the industry.